Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sima Emadi Allahyari"'
Autor:
Farzaneh Darbeheshti, Elham Zokaei, Yaser Mansoori, Sima Emadi Allahyari, Zeeba Kamaliyan, Sepideh Kadkhoda, Javad Tavakkoly Bazzaz, Nima Rezaei, Abbas Shakoori
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Circular RNAs (circRNAs) have been implicated in the initiation and development of breast cancer as functional non-coding RNAs (ncRNA). The roles of circRNAs as the competing endogenous RNAs (ceRNAs) to sponge microRNAs (miRNAs) h
Externí odkaz:
https://doaj.org/article/099935eccec64b4fa8ae307f9c190f28
Autor:
Mir Saeed Yekaninejad, Zahra Hassannejad, Erfan Farazi, Afshin Bahramy, Masoumeh Majidi Zolbin, Narges Zafari, Sima Emadi Allahyari
Publikováno v:
Expert review of molecular diagnostics. 22(4)
Objective: To investigate whether miRNAs have a remarkable pooled diagnostic accuracy, sensitivity, and specificity as noninvasive biomarkers to distinguish endometriosis patients from non-endometriosis women.Methods: A comprehensive literature searc
Autor:
Abbas Shakoori, Sima Emadi Allahyari, Zeeba Kamaliyan, Yaser Mansoori, Farzaneh Darbeheshti, Sepideh Kadkhoda, Nima Rezaei, Javad Tavakkoly Bazzaz, Elham Zokaei
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Cancer Cell International, Vol 21, Iss 1, Pp 1-12 (2021)
Background Circular RNAs (circRNAs) have been implicated in the initiation and development of breast cancer as functional non-coding RNAs (ncRNA). The roles of circRNAs as the competing endogenous RNAs (ceRNAs) to sponge microRNAs (miRNAs) have also
Autor:
Farnaz Hajizadeh, Naime Majidi Zolbanin, Hadi Hassannia, Majid Ahmadi, Ali Masjedi, Angelina Olegovna Zekiy, Seyedeh Mahboubeh Mousavi, Parisa Sahami Gilan, Sima Emadi Allahyari, Farhad Jadidi-Niaragh, Reza Jafari, Mehdi Yousefi, Sepideh Izadi, Hamed Mohammadi, Niloofar Mansouri
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 34:102384
High concentrations of adenosine and interleukin (IL)-6 in the tumor microenvironment have been identified as one of the leading causes of cancer growth. Thus, we decided to inhibit the growth of cancer cells by inhibiting the production of adenosine